Morgan Stanley downgraded Astera Labs (NASDAQ:ALAB) to Equal-weight from Overweight due to full valuation and priced-in product ramps. The firm noted that Astera's stock is approaching its price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback